Variants in Two Gene Members of the TNF Ligand Superfamily and Hepatitis C Virus Chronic Disease

Overview

Journal Gastroenterol Hepatol Bed Bench

Specialty Gastroenterology

Date 2019 Feb 19

PMID 30774809

Citations 7

Authors

Shaghayegh Baradaran Ghavami

Seyed Reza Mohebbi

Khatoon Karimi

Pedram Azimzadeh

Afsaneh Sharifian

Helia Mojahed Yazdi

Behzad Hatami

Affiliations

Soon will be listed here.

Abstract

Aim: To assess the possible correlation between single nucleotide polymorphisms (SNPs) of two members of TNF ligand superfamily genes, tumor necrosis factor-α (TNF-α) and lymphotoxin-α (LTA), and HCV chronic disease.

Background: The causes of disease progression from hepatitis C virus (HCV) infection to chronic liver disease still remains unclear. Abnormal production of the cytokines alleged to be contributed to progression of the disease or viral persistence. Regulatory mechanisms that control the production of cytokines including genetic polymorphisms, especially at coding/regulatory regions of genes, may affect expression and secretion of the cytokines.

Methods: In this case-control investigation, 258 individuals with serologically proven chronic HCV infection and 277 healthy controls were studied. Genotyping of rs1799964 variant of TNF-α and rs909253 intronic variant in LTA gene were performed. To confirm the results of genotyping, 10% of the specimens analyzed again by sequencing approach.

Results: In this investigation, a significant association was observed between the TNF-α TC genotype and chronic HCV infection (P = 0.035). Moreover, the frequency of C allele was significantly different between control subjects in comparison with chronic HCV patients (P=0.02). On the other hand, no association was found between LTA gene polymorphism and susceptibility to chronic HCV infection.

Conclusion: These findings indicate that genetic variants like single nucleotide polymorphism in TNF-α rs1799964, could be a host factor associated with susceptibility to HCV chronic infection. However, further large scale investigations are needed to confirm this finding.

Citing Articles

Host Genetic Variations and Their Implications on HBV and HCV Infection in the Iranian Population: A Comprehensive Systematic Review.

Shamshiri A, Amerizadeh F, Navaei Z, Pasdar A Iran J Public Health. 2024; 53(11):2440-2450.

PMID: 39619899 PMC: 11607151. DOI: 10.18502/ijph.v53i11.16946.

Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System.

Li M, Qin Z, Yu Q, Huang Z, Cheng J, Zhong L Drug Des Devel Ther. 2022; 16:4365-4383.

PMID: 36583113 PMC: 9793729. DOI: 10.2147/DDDT.S385301.

Circulating Profile of ECM-Related Proteins as Diagnostic Markers in Inflammatory Bowel Diseases.

Komosinska-Vassev K, Kaluzna A, Jura-Poltorak A, Derkacz A, Olczyk K J Clin Med. 2022; 11(19).

PMID: 36233486 PMC: 9570505. DOI: 10.3390/jcm11195618.

Obesity, a challenge in the management of inflammatory bowel diseases.

Rajabnia M, Hajimirzaei S, Hatamnejad M, Shahrokh S, Ghavami S, Farmani M Immunol Res. 2022; 70(6):742-751.

PMID: 36031674 DOI: 10.1007/s12026-022-09315-7.

Association of IL-22 and IL-22RA1 gene variants in Iranian patients with colorectal cancer.

Mohebbi S, Karimi K, Rostami F, Kazemian S, Azimzadeh P, Mirtalebi H Gastroenterol Hepatol Bed Bench. 2022; 14(Suppl1):S58-S65.

PMID: 35154603 PMC: 8817752.

References

Martinez A, Fernandez-Arquero M, Pascual-Salcedo D, Conejero L, Alves H, Balsa A . Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum. 2000; 43(6):1366-70. DOI: 10.1002/1529-0131(200006)43:6<1366::AID-ANR21>3.0.CO;2-S. View

Vidigal P, Germer J, Zein N . Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin. J Hepatol. 2002; 36(2):271-7. DOI: 10.1016/s0168-8278(01)00243-4. View

Rosen H, McHutchison J, Conrad A, Lentz J, Marousek G, Rose S . Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol. 2002; 97(3):714-20. DOI: 10.1111/j.1572-0241.2002.05552.x. View

Goyal A, Kazim S, Sakhuja P, Malhotra V, Arora N, Sarin S . Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol. 2003; 72(1):60-5. DOI: 10.1002/jmv.10533. View

Bayley J, Ottenhoff T, Verweij C . Is there a future for TNF promoter polymorphisms?. Genes Immun. 2004; 5(5):315-29. DOI: 10.1038/sj.gene.6364055. View

Vassalli P . The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992; 10:411-52. DOI: 10.1146/annurev.iy.10.040192.002211. View

Valenti L, Pulixi E, Fracanzani A, Dongiovanni P, Maggioni M, Orsatti A . TNFalpha genotype affects TNFalpha release, insulin sensitivity and the severity of liver disease in HCV chronic hepatitis. J Hepatol. 2005; 43(6):944-50. DOI: 10.1016/j.jhep.2005.05.035. View

Dai C, Chuang W, Chang W, Chen S, Lee L, Hsieh M . Tumor necrosis factor- alpha promoter polymorphism at position -308 predicts response to combination therapy in hepatitis C virus infection. J Infect Dis. 2005; 193(1):98-101. DOI: 10.1086/498244. View

Taremi M, Mehdi Soltan Dallal M, Gachkar L, MoezArdalan S, Zolfagharian K, Zali M . Prevalence and antimicrobial resistance of Campylobacter isolated from retail raw chicken and beef meat, Tehran, Iran. Int J Food Microbiol. 2006; 108(3):401-3. DOI: 10.1016/j.ijfoodmicro.2005.12.010. View

10.

Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R . Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine. 2006; 34(1-2):24-31. DOI: 10.1016/j.cyto.2006.03.011. View

11.

Messer G, Spengler U, Jung M, Honold G, Blomer K, Pape G . Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med. 1991; 173(1):209-19. PMC: 2118757. DOI: 10.1084/jem.173.1.209. View

12.

Paladino N, Fainboim H, Theiler G, Schroder T, Munoz A, Flores A . Gender susceptibility to chronic hepatitis C virus infection associated with interleukin 10 promoter polymorphism. J Virol. 2006; 80(18):9144-50. PMC: 1563933. DOI: 10.1128/JVI.00339-06. View

13.

Suruki R, Mueller N, Hayashi K, Harn D, DeGruttola V, Raker C . Host immune status and incidence of hepatocellular carcinoma among subjects infected with hepatitis C virus: a nested case-control study in Japan. Cancer Epidemiol Biomarkers Prev. 2006; 15(12):2521-5. DOI: 10.1158/1055-9965.EPI-06-0485. View

14.

Gaudet M, Egan K, Lissowska J, Newcomb P, Brinton L, Titus-Ernstoff L . Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet. 2007; 121(3-4):483-90. DOI: 10.1007/s00439-006-0315-x. View

15.

Chen T, Hsieh Y, Wu T, Yang S, Wu C, Tsay G . Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Transl Res. 2007; 150(2):116-21. DOI: 10.1016/j.trsl.2007.01.007. View

16.

Akkaya O, Kiyici M, Yilmaz Y, Ulukaya E, Yerci O . Clinical significance of activity of ALT enzyme in patients with hepatitis C virus. World J Gastroenterol. 2007; 13(41):5481-5. PMC: 4171283. DOI: 10.3748/wjg.v13.i41.5481. View

17.

Jeng J, Tsai J, Chuang L, Ho M, Lin Z, Hsieh M . Tumor necrosis factor-alpha 308.2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia. 2007; 9(11):987-92. PMC: 2077890. DOI: 10.1593/neo.07781. View

18.

Puthothu B, Bierbaum S, Kopp M, Forster J, Heinze J, Weckmann M . Association of TNF-alpha with severe respiratory syncytial virus infection and bronchial asthma. Pediatr Allergy Immunol. 2008; 20(2):157-63. DOI: 10.1111/j.1399-3038.2008.00751.x. View

19.

Zekri A, Hafez M, Bahnassy A, Hassan Z, Mansour T, Kamal M . Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary study. BMC Res Notes. 2008; 1:106. PMC: 2584108. DOI: 10.1186/1756-0500-1-106. View

20.

Elsammak M, Al-Sharkaweey R, Ragab M, Amin G, Kandil M . In Egyptians, a mutation in the lymphotoxin-alpha gene may increase susceptibility to hepatitis C virus but not that to schistosomal infection. Ann Trop Med Parasitol. 2008; 102(8):709-16. DOI: 10.1179/136485908X337599. View